[go: up one dir, main page]

CN1071581A - The compound method of Antiheptitic " Ganyanling " - Google Patents

The compound method of Antiheptitic " Ganyanling " Download PDF

Info

Publication number
CN1071581A
CN1071581A CN 91106266 CN91106266A CN1071581A CN 1071581 A CN1071581 A CN 1071581A CN 91106266 CN91106266 CN 91106266 CN 91106266 A CN91106266 A CN 91106266A CN 1071581 A CN1071581 A CN 1071581A
Authority
CN
China
Prior art keywords
radix
ganyanling
antiheptitic
angelicae sinensis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 91106266
Other languages
Chinese (zh)
Inventor
孙明君
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 91106266 priority Critical patent/CN1071581A/en
Publication of CN1071581A publication Critical patent/CN1071581A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A kind of by following amount preparation " Antiheptitic " Ganyanling " ": Alumen preparata 0.5-1.5, Fructus Jujubae 6-10, Radix Salviae Miltiorrhizae 4-8, Radix Angelicae Sinensis 5-8, the Radix Astragali 5-8, Massa Medicata Fermentata 4, Fructus Schisandrae Chinensis 3, the preparation method that above unit calculates with gram.Clinical treatment hepatitis A patient 100 many cases.Take medicine a course of treatment, 98% patient transaminase recovers normally, the liver spleen obviously bounces back.Take medicine two courses of treatment, 95% hepatitis liver function recovery is normal, total effective rate 100%.

Description

The compound method of Antiheptitic " Ganyanling "
The invention provides a kind of compound method for the treatment of Chinese medicine-" Antiheptitic " Ganyanling " " of hepatitis disease, belong to the compound method of medicine.
Hepatitis is that a kind of sickness rate height, treatment time are long, the healthy infectious disease of serious harm people.At present, the Western medicine for the treatment of this kind disease exists administration time long mostly, the deficiency that curative effect is stable inadequately.
At the above-mentioned deficiency of existing treatment hepatitis medicament, the purpose of this invention is to provide a kind of determined curative effect, treat the compound method of hepatitis medicament " Antiheptitic " Ganyanling " " rapidly.
By the preparation of following amount " Antiheptitic " Ganyanling ":
Alumen preparata 0.5-1.5
Fructus Jujubae 6-10
Radix Salviae Miltiorrhizae 4-8
Radix Angelicae Sinensis 5-8
Radix Astragali 5-8
Massa Medicata Fermentata 4
Fructus Schisandrae Chinensis 3
Above unit calculates with gram, dosage 30 grams on the one, and 15 days is a course of treatment.
Compound method:
1, Alumen preparata intensive drying can be fried in iron pan to taupe, reaches exclusion, and no special odor is degree.
2, after Fructus Jujubae is cleaned, enucleation dries, inserted in the drying baker baking temperature 80-85 ° drier 48 hours.
3, Radix Angelicae Sinensis, the Radix Astragali, Radix Salviae Miltiorrhizae, Massa Medicata Fermentata fully dry, pulverize separately.
4, by the prescription amount of giving, get the medicine of respectively distinguishing the flavor of and fully be mixed and made into powder, can honey be ball also, or make tablet.
Clinical treatment hepatitis A patient 100 many cases.Take medicine recover normally a course of treatment, 98% patient transaminase, the liver spleen obviously bounces back.Take medicine two courses of treatment, 95% hepatitis liver function recovery are normal, total effective rate 100%.
Below by most preferred embodiment, further narrate the technology of the present invention feature.
The Antiheptitic " Ganyanling " prescription: with the gram metering, dose on the one,
Alumen preparata 0.8-1.3
Fructus Jujubae 6
Radix Salviae Miltiorrhizae 4
Radix Angelicae Sinensis 6
The Radix Astragali 6
Massa Medicata Fermentata 4
Fructus Schisandrae Chinensis 3
Compound method:
1, Alumen preparata is put into iron pan and is fried to taupe, to exclusion, no special odor and be degree.
2, Fructus Jujubae is cleaned, and goes in the drying baker 80 ° of baking temperatures after enucleation is dried dry 48 hours.
3, Radix Angelicae Sinensis, the Radix Astragali, Radix Salviae Miltiorrhizae, Massa Medicata Fermentata fully dry, pulverize separately.
4, by the prescription amount of giving, get the abundant mixed powder of the medicine of respectively distinguishing the flavor of or be equipped with excipient and make tablet, honeyed pill.
Take the hepatitis A patient of present embodiment described " Antiheptitic " Ganyanling " ", a course cure rate 30%, two course cure rates 68% of taking medicine, effective percentage 100%.Take 2 courses of treatment of this medicine, can make 95% the inverted liver cirrhosis patient albumin of albumen ratio amount recover normal.Clinical statistics shows, takes two courses of treatment of this medicine, 10% hepatitis B patient, HBSAg(Australia antigen) turn out cloudy.

Claims (2)

1, a kind of compound method for the treatment of Chinese medicine-" Antiheptitic " Ganyanling " " of hepatitis disease, it is characterized by by the preparation of following amount " Antiheptitic " Ganyanling ":
Alumen preparata 0.5-1.5
Fructus Jujubae 6-10
Radix Salviae Miltiorrhizae 4-8
Radix Angelicae Sinensis 5-8
Radix Astragali 5-8
Massa Medicata Fermentata 4
Fructus Schisandrae Chinensis 3
Above unit calculates with gram;
Compound method:
(1) Alumen preparata intensive drying can be fried in iron pan to taupe, reaches exclusion, and no special odor is degree;
(2) after Fructus Jujubae is cleaned, enucleation dries, inserted in the drying baker baking temperature 80-85 ° drier 48 hours;
(3) Radix Angelicae Sinensis, the Radix Astragali, Radix Salviae Miltiorrhizae, Massa Medicata Fermentata fully dry, pulverize separately;
(4) by the prescription amount of giving, get the medicine of respectively distinguishing the flavor of and fully be mixed and made into powder, can honey be ball also, or make tablet.
2, a kind of outfit method for the treatment of Chinese medicine-" Antiheptitic " Ganyanling " " of hepatitis disease according to claim 1 is characterized by the Antiheptitic " Ganyanling " prescription: with gram metering, dose on the one
Alumen preparata 0.8-1.3
Fructus Jujubae 6
Radix Salviae Miltiorrhizae 4
Radix Angelicae Sinensis 6
The Radix Astragali 6
Massa Medicata Fermentata 4
Fructus Schisandrae Chinensis 3
Compound method:
(1) Alumen preparata is put into iron pan and is fried to taupe, to exclusion, no special odor and be degree;
(2) Fructus Jujubae is cleaned, and goes in the drying baker 80 ° of baking temperatures after enucleation is dried dry 48 hours;
(3) Radix Angelicae Sinensis, the Radix Astragali, Radix Salviae Miltiorrhizae, Massa Medicata Fermentata fully dry, pulverize separately;
(4) by the prescription amount of giving, get the abundant mixed powder of the medicine of respectively distinguishing the flavor of or be equipped with excipient and make tablet, honeyed pill.
CN 91106266 1991-10-19 1991-10-19 The compound method of Antiheptitic " Ganyanling " Pending CN1071581A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 91106266 CN1071581A (en) 1991-10-19 1991-10-19 The compound method of Antiheptitic " Ganyanling "

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 91106266 CN1071581A (en) 1991-10-19 1991-10-19 The compound method of Antiheptitic " Ganyanling "

Publications (1)

Publication Number Publication Date
CN1071581A true CN1071581A (en) 1993-05-05

Family

ID=4907700

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 91106266 Pending CN1071581A (en) 1991-10-19 1991-10-19 The compound method of Antiheptitic " Ganyanling "

Country Status (1)

Country Link
CN (1) CN1071581A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1052148C (en) * 1995-04-03 2000-05-10 张少平 "Zhongniankang" beverage for health of middle aged people
CN1054042C (en) * 1993-05-15 2000-07-05 崔继利 Liver peptide and its producing method
CN1060656C (en) * 1995-06-29 2001-01-17 郝玉生 Yugan Wan
CN1069528C (en) * 1996-01-22 2001-08-15 刘墨林 "Mieyidan" pill for treating hepatitis and producing process thereof
WO2005079823A1 (en) * 2004-02-19 2005-09-01 Phynova Limited Plant-based medicament for the treatment of hepatitis c
WO2007020382A3 (en) * 2005-08-12 2007-05-31 Phynova Ltd Plant-based medicament for the treatment of liver disease

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1054042C (en) * 1993-05-15 2000-07-05 崔继利 Liver peptide and its producing method
CN1052148C (en) * 1995-04-03 2000-05-10 张少平 "Zhongniankang" beverage for health of middle aged people
CN1060656C (en) * 1995-06-29 2001-01-17 郝玉生 Yugan Wan
CN1069528C (en) * 1996-01-22 2001-08-15 刘墨林 "Mieyidan" pill for treating hepatitis and producing process thereof
WO2005079823A1 (en) * 2004-02-19 2005-09-01 Phynova Limited Plant-based medicament for the treatment of hepatitis c
JP2007523144A (en) * 2004-02-19 2007-08-16 ファイノバ・リミテッド Botanical medicine for treating hepatitis C
US7422760B2 (en) 2004-02-19 2008-09-09 Phynova Limited Plant-based medicament for the treatment of Hepatitis C
EA014234B1 (en) * 2004-02-19 2010-10-29 Финова Лимитед Composition for the treatment of hepatitis c or dietary supplement for prevention or alleviation hepatitis c symptoms
WO2007020382A3 (en) * 2005-08-12 2007-05-31 Phynova Ltd Plant-based medicament for the treatment of liver disease

Similar Documents

Publication Publication Date Title
CN1245707A (en) Chinese medicine for curing AIDS and carcinomatosis
CN1071581A (en) The compound method of Antiheptitic " Ganyanling "
CN1100642A (en) Chinese medicine preparation for treating viral hepatitis B
CN1150926C (en) Medicine for treating hepatism
CN100400094C (en) Traditional Chinese medicine for treating hepatitis B and its preparing process
CN100534506C (en) Traditional Chinese medicine composition for treating viral hepatitis
CN1054515C (en) Medicine for prevention and cure of hepatitis B
CN1066628C (en) Medicine for chronic hepatitis B and its preparation
CN118634299A (en) A Chinese medicine composition for treating non-alcoholic fatty liver disease and preparation method thereof
CN1074292C (en) Cancer treating medicine capsule
CN1090183A (en) Artemisia scoparia and ginseng pellet for mourishing liver and method for production thereof
CN1164294C (en) Liver cancer resisting medicine
CN1141970C (en) Compound Chinese medicine tea bag for curing fatty liver and hyperlipemia and its production method
CN1096681A (en) Hepatosis treating medicine powder
CN101007113B (en) Shenling Chinese medicine preparation for treating acute and chronic hepatitis and its preparation method
CN1086129C (en) Hepatitis restoration pill
CN1322534A (en) Hepatitis treating Chinese medicine and its preparation
CN1136896C (en) Live-nourishing 'yanggan' pill
CN1340353A (en) Orally-applied medicine for treating hepatism and its preparing process
CN1403140A (en) Medicine for treating acute and chronic hepatitis B
CN1613475A (en) Chinese medicine for treating liver diseases
CN1061885C (en) Specific infusion for hepatitis B and producing process thereof
CN1086949C (en) Chinese medicine for hepatitis B and its preparation
CN1073852C (en) Medicine powder for treating hepatitis A and hepatitis B
CN100353987C (en) Chinese medicinal preparation for treating acne

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication